Page last updated: 2024-08-17

quinoxalines and Glaucoma

quinoxalines has been researched along with Glaucoma in 139 studies

Research

Studies (139)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's22 (15.83)18.2507
2000's77 (55.40)29.6817
2010's35 (25.18)24.3611
2020's5 (3.60)2.80

Authors

AuthorsStudies
Chambers, A; Cumpston, KL; Kershner, E; Tobarran, N; Wills, BK1
Bigdeli, A; Feghhi, M; Makhmalzadeh, BS; SoleimaniBiatiani, E1
Kim, KE; Kim, Y; Lee, CK; Rho, S; Shin, J1
Alkahtani, HM; Alomar, AM; Bakheit, AH; Darwish, H1
Kurysheva, NI2
Aiello, F; Bagetta, G; Cesareo, M; Corasaniti, MT; Nucci, C; Scuteri, D; Tonin, P1
Abd-Elgawad, AE; Ibrahim, MM; Jablonski, MM; Soliman, OA1
Iotova, V; Kiryazov, K; Stefova, M1
Fukuchi, T1
Cherukury, M; Durairaj, C; Shen, J1
Hallböök, F; Harun-Or-Rashid, M; Lindqvist, N1
Harada, C; Harada, T; Kimura, A; Mitamura, Y; Namekata, K; Semba, K1
Chew, SK; Goldberg, I; Skalicky, SE1
Guzman-Aranguez, A; Loma, P; Perez de Lara, MJ; Pintor, J1
Batoosingh, AL; Cantor, LB; Liu, CC; Safyan, E1
Agey, P; Dong, CJ; Guo, Y; Hare, WA; Wheeler, L1
Motolko, MA1
Batiste, C; Fudemberg, SJ; Katz, LJ1
Călugăru, D; Călugăru, M2
Delgado-Ortega, L; Díaz-Cerezo, S; Pinazo-Durán, MD; Soto-Alvarez, J; Vinuesa-Silva, I; Vinuesa-Silva, JM1
Mint, JO; Poling, TR; Schultz, CL1
Karczewicz, D; Kuprjanowicz, L1
Cheng, JW; Li, Y; Wei, RL1
Augustinus, B; De Smet, MD; Hondeghem, K1
Earl, M; Nguyen, QH1
Campos, JG; Díaz, F; Moreno, M; Pérez de Vargas, I; Vidal, L; Villena, A1
Katz, LJ; Razeghinejad, MR; Sawchyn, AK1
Montgomery, DM; Rahman, MQ; Ramaesh, K1
Adams, BH; Broderick, DF; Menke, DM; Runyan, BR; Shetty, RK; Tun, HW1
Dermon, C; Panagis, L; Prokosch, V; Thanos, S; Volk, GF1
Alldredge, B; Gerhardt, G; Halverson, K; Pensyl, D; Qualls, C; Sullivan-Mee, M1
Artunay, O; Bahcecioglu, H; Rasier, R; Sengul, A; Unal, M; Yuzbasioglu, E1
Bernstein, P; Caprioli, J; Schiffman, RM; Spaeth, GL1
Hendrikse, F; Peeters, A; Prins, MH; Schouten, JS; Webers, CA1
Abdlseaed, AA; Abeysinghe, SS; Kelly, S; Montgomery, DM; Rahman, MQ; Roskell, NS; Shannon, PR1
Crichton, A; Fielden, M; Hall, R; Kherani, A; Kherani, F1
Maiti, S; Mondol, R; Paul, S; Ray, S; Sa, B1
Bhagav, P; Chandran, S; Upadhyay, H1
Arriola-Villalobos, P; Díaz-Valle, D; Garcia-Gil-de-Bernabé, J; Iglesias-Lodares, I1
Holden, CA; Jadhav, G; Kadam, R; Kompella, UB; Thakur, A; Tyagi, P; Yang, H1
Aburahma, MH; Mahmoud, AA1
Geethalakshmi, A; Jha, SK; Karki, R; Nikunj, B; Venkatesh, DP1
Cottingham, AJ; Hollander, DA; Katz, LJ; Rauchman, SH; Schiffman, RM; Simmons, ST; Williams, JM1
Congdon, NG; Friedman, DS; Gilbert, D; Goggins, W; Kader, MA; Krishnadas, R; Quigley, HA; Ramakrishnan, R; Tielsch, J1
Chang, TH; Chen, FA; Chien, ST; Horng, CT; Kao, WT; Tsai, MK; Tsai, ML1
Inoue, Y; Kaneko, E; Minagawa, Y; Wada, T1
Méndez-Hernández, C1
Carrasco, MA; Schlaen, BA; Zárate, JO1
Holló, G; Kóthy, P1
Cho, J; Mullins, CD; Shaya, FT; Wong, W1
Baudouin, C; Titouamane, S1
Naskar, R; Quinto, K; Schuettauf, F; Zurakowski, D1
Phelan, P1
Cheng, CY; Chou, JC; Hsu, WM; Ko, YC; Liu, CJ; Liu, JH1
Coracas, A; Eckhardt, C; Sauer, S1
Kim, P; Lertsumikul, S1
Batoosingh, A; Felix, C; Mundorf, T; Whitcup, S; Williams, R1
Koren, G; Levin, AV; Mungan, NK; Nischal, KK; Wilson, TW1
Fong, JC; Hong, SJ; Wang, HZ; Wu, KY1
Lai, R; Wheeler, L; WoldeMussie, E1
Chen, MJ; Chou, JC; Hsu, WM; Liu, JH1
Mozaffari, E; Reardon, G; Schwartz, GF1
Assalian, A; Castilloux, AM; Houde, M; LeLorier, J; Tingey, D1
Bowman, RJ; Cope, J; Nischal, KK1
Bonini, S; Bucci, MG; Centofanti, M; Manni, G; Oddone, F; Parravano, M; Sacchetti, M1
Cunliffe, I; García-Sánchez, J; Landry, J; Pajic, B; Rouland, JF; Spiegel, D; Traverso, C1
Becker, HI; Diamant, JI; Walton, RC; Zegans, ME1
McKay, IC; Montgomery, DM; Morris, D; Osborne, SA1
Appaswamy, S; Bhatt, R; Desai, A; Fitt, A; Sandramouli, S; Whittaker, KW1
Ignat, F1
Cheng, CY; Hsu, WM; Ko, YC; Liu, CJ1
Burnier, MN; Saheb, NE; Saraiva, VS; Solari, HP; Ventura, MP; Vianna, RN1
Cheetham, JK; Chou, C; Craven, ER; Schiffman, R; Walters, TR; Williams, R1
Al-Jadaan, I; Al-Omran, M; Al-Shahwan, S; Al-Torbak, AA; Edward, DP; Turkmani, S1
Susanna, R; Vaidergorn, PG1
Márquez-de-Aracena, R; Montero-de-Espinosa, I; Morales, C1
Avila, MP; Magacho, L; Queiroz, CF; Reis, R; Santos, LC1
Daubert, GP1
Jurisić, D; Lacmnovic-Loncar, V; Mandić, Z; Petric, I; Sesar, A; Sesar, I; Tomić, Z1
Baudouin, C; Bron, AM; Creuzot-Garcher, C; Lizard, G; Malvitte, L; Montange, T; Vejux, A1
Craig, JC; Fung, AT; Healey, PR; Jones, MP; McCluskey, PJ; Reid, SE1
Fiscella, R1
Feldman, RM1
Goñi, FJ1
Greenfield, DS; Krupin, T; Liebmann, JM; Ritch, R1
Heimann, K; Hoernchen, H; Merz, U; Peschgens, T; Wenzl, T1
Craven, ER; Katz, LJ; Simmons, ST1
Barnes, D; Ducruet, T; Foerster, V; Hodge, WG; Lachaine, J; Morrison, A; Murray, C; Steffensen, I1
Day, DG; Hollander, DA1
Craig, JC; Fung, A; Liew, G; Loon, SC; Reid, SE1
Serle, JB1
Barnebey, HS; Chen, KS; Cinotti, DJ; Coleman, AL; Hersh, SB; Lewis, RA; Morrison, JC; Robin, AL; Walt, J; Zimmerman, TJ1
Clevenger, CE; David, R; Henry, JC; Passo, MS; Perell, HF; Siegel, LI; Spaeth, GL; Stamper, RL; Stiles, MC; Walt, JG1
Burke, J; Schwartz, M1
Hill, R1
Greenfield, DS; Liebmann, JM; Ritch, R1
Crichton, AC1
Gordon, RN; Greenfield, DS; Lama, P; Liebmann, JM; Ritch, R1
Hoyng, PF; Rasker, MT1
Mermoud, A1
Edward, DP; Lark, KK; Pasha, AS; Yan, X1
Gebhardt, DO1
Burnstein, Y; Robin, AL1
Assalian, A; Chevrier, RL; Duperré, J; Lesk, MR1
Buys, YM; thoe Schwartzenberg, GW1
Grote, A; Korsch, E; Seybold, M; Soditt, V1
Barbe, ME; Carlsen, JO; Kwon, YH; Scott, WE; Zabriskie, NA1
Hudgins, AC; Pruitt, CA; Sine, C; Stewart, WC1
Ainsworth, J; Kulshrestha, M; Ng, S; Roff, E; Sedgwick, G1
Carlsson, AM; Chauhan, BC; Leblanc, RP; Lee, AA1
Apătăchioae, I; Chiseliţă, D1
David, R; Melamed, S1
Javitt, JC; Schiffman, RM1
Gross, RL; Orengo-Nania, S; Williams, GC1
Byles, DB; Frith, P; Salmon, JF1
Detry-Morel, M; Dutrieux, C1
Gagliuso, DJ; Podos, SM; Serle, JB; Wang, RF1
Einarson, TR; Iskedjian, M; Kulin, NA; Tingey, D1
Cantor, LB1
Lagrèze, WA1
Simmons, ST1
Chalmers-Redman, RM; Mittag, TW; Podos, SM; Sud, A; Tatton, WG1
Chew, P; Lat-Luna, M; Lim, BA; Tan, D; Xiong, X1
Ahmed, FA; Chaudhary, P; Hegazy, K; Sharma, SC1
Enyedi, LB; Freedman, SF1
Maroteaux, I1
Grehn, F1
Azuara-Blanco, A; Bain, M; Bateman, DN; Clark, R; Forrest, J2
Blondeau, P; Rousseau, JA1
Katz, LJ1
Maurin, JF; May, F; Renard, JP; Rigal-Sastourne, JC1
Kasahara, N1
Martone, JF; Mead, A; O'Connor, DJ1

Reviews

25 review(s) available for quinoxalines and Glaucoma

ArticleYear
Evidence on the neuroprotective properties of brimonidine in glaucoma.
    Progress in brain research, 2020, Volume: 257

    Topics: Brimonidine Tartrate; Glaucoma; Humans; Intraocular Pressure; Quinoxalines; Randomized Controlled Trials as Topic; Vision Disorders; Visual Fields

2020
Brinzolamide plus brimonidine for the treatment of glaucoma: an update.
    Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:16

    Topics: Adrenergic alpha-2 Receptor Agonists; Antihypertensive Agents; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Clinical Trials as Topic; Drug Combinations; Glaucoma; Humans; Intraocular Pressure; Quinoxalines; Sulfonamides; Thiazines

2014
Efficacy, safety, and current applications of brimonidine.
    Expert opinion on drug safety, 2008, Volume: 7, Issue:6

    Topics: Animals; Antihypertensive Agents; Brimonidine Tartrate; Drug Combinations; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Timolol; Treatment Outcome

2008
[Fixed combinations of glaucoma medications].
    Oftalmologia (Bucharest, Romania : 1990), 2008, Volume: 52, Issue:3

    Topics: Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Cloprostenol; Drug Combinations; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Travoprost; Treatment Outcome

2008
[Development of conjunctival hyperemia with the use of a fixed combination of latanoprost/timolol: systematic review and meta-analysis of clinical trials].
    Archivos de la Sociedad Espanola de Oftalmologia, 2009, Volume: 84, Issue:4

    Topics: Aged; Brimonidine Tartrate; Clinical Trials as Topic; Cloprostenol; Conjunctival Diseases; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Glaucoma; Humans; Hyperemia; Latanoprost; Middle Aged; Ocular Hypertension; Odds Ratio; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Timolol; Travoprost

2009
[Neuroprotection in glaucoma].
    Annales Academiae Medicae Stetinensis, 2007, Volume: 53 Suppl 1

    Topics: Betaxolol; Brimonidine Tartrate; Disease Progression; Glaucoma; Guanidines; Humans; Memantine; Neuroprotective Agents; Quinoxalines; Sulfonamides; Thiophenes

2007
Systematic review of intraocular pressure-lowering effects of adjunctive medications added to latanoprost.
    Ophthalmic research, 2009, Volume: 42, Issue:2

    Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Databases, Factual; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Optic Nerve Diseases; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Thiophenes; Timolol

2009
Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.
    Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:6

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Drug Combinations; Glaucoma; Humans; Intraocular Pressure; Patient Selection; Quinoxalines; Risk Assessment; Sulfonamides; Thiophenes; Timolol; Treatment Outcome

2010
Brimonidine for glaucoma.
    Expert opinion on drug safety, 2010, Volume: 9, Issue:3

    Topics: Adrenergic alpha-Agonists; Animals; Antihypertensive Agents; Brimonidine Tartrate; Glaucoma; Humans; Intraocular Pressure; Quinoxalines

2010
[The latest developments in glaucoma therapy using fixed combination products].
    Oftalmologia (Bucharest, Romania : 1990), 2011, Volume: 55, Issue:3

    Topics: Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate, Timolol Maleate Drug Combination; Carbonic Anhydrase Inhibitors; Cloprostenol; Drug Combinations; Drug Therapy, Combination; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Thiophenes; Timolol; Travoprost; Treatment Outcome

2011
Reappraising first-line treatment in glaucoma management.
    Hospital medicine (London, England : 1998), 2002, Volume: 63, Issue:9

    Topics: Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Cloprostenol; Dinoprost; Drug Therapy, Combination; Glaucoma; Humans; Latanoprost; Lipids; Prostaglandins; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Travoprost

2002
Role of alpha-2 agonists in neuroprotection.
    Survey of ophthalmology, 2003, Volume: 48 Suppl 1

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Glaucoma; Humans; Neuroprotective Agents; Quinoxalines; Receptors, Adrenergic, alpha-2; Retinal Ganglion Cells

2003
Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma.
    The British journal of ophthalmology, 2007, Volume: 91, Issue:1

    Topics: Administration, Topical; Aged; Antihypertensive Agents; Brimonidine Tartrate; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Randomized Controlled Trials as Topic; Treatment Outcome

2007
Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.
    Current medical research and opinion, 2007, Volume: 23, Issue:12

    Topics: Antihypertensive Agents; Brimonidine Tartrate; Clinical Trials as Topic; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Male; Ocular Hypertension; Quinoxalines; Sulfonamides; Thiophenes; Treatment Outcome

2007
The efficacy and harm of prostaglandin analogues for IOP reduction in glaucoma patients compared to dorzolamide and brimonidine: a systematic review.
    The British journal of ophthalmology, 2008, Volume: 92, Issue:1

    Topics: Adult; Aged; Antihypertensive Agents; Brimonidine Tartrate; Female; Glaucoma; Humans; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Prostaglandins, Synthetic; Quinoxalines; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes; Treatment Outcome

2008
Meta-analysis of randomized controlled trials comparing timolol with brimonidine in the treatment of glaucoma.
    Clinical & experimental ophthalmology, 2008, Volume: 36, Issue:3

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Brimonidine Tartrate; Glaucoma; Humans; Quinoxalines; Randomized Controlled Trials as Topic; Timolol; Treatment Outcome

2008
Pharmacological advances in the treatment of glaucoma.
    Drugs & aging, 1994, Volume: 5, Issue:3

    Topics: Administration, Topical; Adrenergic alpha-Agonists; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Clonidine; Ethacrynic Acid; Glaucoma; Humans; Latanoprost; Prostaglandins; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes

1994
Preclinical evaluation of brimonidine.
    Survey of ophthalmology, 1996, Volume: 41 Suppl 1

    Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Cats; Cebus; Drug Evaluation, Preclinical; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Rabbits; Rats

1996
Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment.
    Journal of glaucoma, 1997, Volume: 6, Issue:4

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Betaxolol; Brimonidine Tartrate; Clinical Trials as Topic; Dose-Response Relationship, Drug; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Timolol; Trabeculectomy

1997
[Four new drugs for glaucoma: apraclonidine, brimonidine, dorzolamide and latanoprost].
    Nederlands tijdschrift voor geneeskunde, 1998, Sep-26, Volume: 142, Issue:39

    Topics: Administration, Oral; Administration, Topical; Adrenergic alpha-Agonists; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Clonidine; Drug Therapy, Combination; Female; Glaucoma; Humans; Latanoprost; Male; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes

1998
[Alpha-2 adrenergic agonists in the treatment of glaucoma].
    Oftalmologia (Bucharest, Romania : 1990), 1999, Volume: 47, Issue:2

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Brimonidine Tartrate; Clonidine; Glaucoma; Humans; Intraocular Pressure; Quinoxalines

1999
Meta-analysis of the effect of latanoprost and brimonidine on intraocular pressure in the treatment of glaucoma.
    Clinical therapeutics, 2000, Volume: 22, Issue:12

    Topics: Brimonidine Tartrate; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Prostaglandins F, Synthetic; Quinoxalines

2000
The evolving pharmacotherapeutic profile of brimonidine, an alpha 2-adrenergic agonist, after four years of continuous use.
    Expert opinion on pharmacotherapy, 2000, Volume: 1, Issue:4

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Glaucoma; Humans; Neuroprotective Agents; Ocular Hypertension; Quinoxalines; Receptors, Adrenergic, alpha-2

2000
Maintaining mitochondrial membrane impermeability. an opportunity for new therapy in glaucoma?
    Survey of ophthalmology, 2001, Volume: 45 Suppl 3

    Topics: Animals; Apoptosis; bcl-X Protein; Brimonidine Tartrate; Cell Membrane Permeability; Glaucoma; Humans; Intraocular Pressure; Mitochondria; Pargyline; Propylamines; Proto-Oncogene Proteins c-bcl-2; Quinoxalines; Retinal Ganglion Cells; Signal Transduction

2001
[New medical treatments of glaucoma. New strategies?].
    Journal francais d'ophtalmologie, 2001, Volume: 24, Issue:10

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Drug Therapy, Combination; Glaucoma; Humans; Prostaglandins; Quinoxalines

2001

Trials

33 trial(s) available for quinoxalines and Glaucoma

ArticleYear
Comparisons of efficacy and safety between preserved and preservative-free brimonidine tartrate in glaucoma and ocular hypertension: a parallel-grouped, randomized trial.
    Scientific reports, 2023, 04-07, Volume: 13, Issue:1

    Topics: Antihypertensive Agents; Brimonidine Tartrate; Double-Blind Method; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Preservatives, Pharmaceutical; Quinoxalines; Treatment Outcome

2023
Brimonidine-purite 0.1% versus brimonidine-purite 0.15% twice daily in glaucoma or ocular hypertension: a 12-month randomized trial.
    Current medical research and opinion, 2008, Volume: 24, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Double-Blind Method; Drug Administration Schedule; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quinoxalines; Treatment Outcome

2008
Comparison of allergy rates in glaucoma patients receiving brimonidine 0.2% monotherapy versus fixed-combination brimonidine 0.2%-timolol 0.5% therapy.
    Current medical research and opinion, 2008, Volume: 24, Issue:9

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Brimonidine Tartrate; Conjunctivitis, Allergic; Drug Therapy, Combination; Female; Glaucoma; Humans; Male; Middle Aged; Quinoxalines; Timolol

2008
Fixed-combination brimonidine/timolol as adjunctive therapy to a prostaglandin analog: a 3-month, open-label, replacement study in glaucoma patients.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2009, Volume: 25, Issue:6

    Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Drug Combinations; Drug Hypersensitivity; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Time Factors; Timolol

2009
Bimatoprost 0.03% versus brimonidine 0.2% in the prevention of intraocular pressure spike following neodymium:yttrium–aluminum–garnet laser posterior capsulotomy.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010, Volume: 26, Issue:5

    Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Capsule Opacification; Cataract; Cloprostenol; Female; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Neodymium; Ocular Hypertension; Ophthalmic Solutions; Posterior Capsule of the Lens; Quinoxalines; Tonometry, Ocular

2010
Control of intraocular pressure and fluctuation with fixed-combination brimonidine-timolol versus brimonidine or timolol monotherapy.
    American journal of ophthalmology, 2011, Volume: 151, Issue:1

    Topics: Antihypertensive Agents; Brimonidine Tartrate; Circadian Rhythm; Double-Blind Method; Drug Combinations; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Quinoxalines; Timolol; Tonometry, Ocular

2011
Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.
    Current medical research and opinion, 2012, Volume: 28, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Drug Combinations; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Time Factors; Timolol; Treatment Outcome

2012
A study of initial therapy for glaucoma in southern India: India Glaucoma Outcomes and Treatment (INGOT) Study.
    Ophthalmic epidemiology, 2012, Volume: 19, Issue:3

    Topics: Aged; Antihypertensive Agents; Antimetabolites, Antineoplastic; Brimonidine Tartrate; Drug Combinations; Female; Fluorouracil; Glaucoma; Humans; India; Intraocular Pressure; Latanoprost; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Surveys and Questionnaires; Thiophenes; Timolol; Tonometry, Ocular; Trabeculectomy; Visual Acuity

2012
Does glaucoma medication influence the diameter of the retinal arteriole in the human eye? (A pilot study using the retinal vessel analyser).
    Acta physiologica Hungarica, 2001, Volume: 88, Issue:3-4

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Arterioles; Betaxolol; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Glaucoma; Humans; Latanoprost; Middle Aged; Ophthalmology; Pilot Projects; Prostaglandins F, Synthetic; Quinoxalines; Retinal Artery; Sulfonamides; Thiazines; Timolol

2001
[Use of brimonidine 0.2% in treatment of glaucoma or ocular hypertony after poorly tolerated beta-blocker treatment].
    Journal francais d'ophtalmologie, 2002, Volume: 25, Issue:6

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Appetite; Brimonidine Tartrate; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Patient Satisfaction; Quality of Life; Quinoxalines; Surveys and Questionnaires; Treatment Failure; Treatment Outcome

2002
Effect of latanoprost 0.005% and brimonidine tartrate 0.2% on pulsatile ocular blood flow in normal tension glaucoma.
    The British journal of ophthalmology, 2002, Volume: 86, Issue:11

    Topics: Adult; Aged; Antihypertensive Agents; Brimonidine Tartrate; Cross-Over Studies; Eye; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Pulsatile Flow; Quinoxalines

2002
A 3-month comparison of efficacy and safety of brimonidine-purite 0.15% and brimonidine 0.2% in patients with glaucoma or ocular hypertension.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2003, Volume: 19, Issue:1

    Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Conjunctiva; Conjunctivitis, Allergic; Dose-Response Relationship, Drug; Double-Blind Method; Glaucoma; Humans; Hyperemia; Intraocular Pressure; Ocular Hypertension; Quinoxalines; Severity of Illness Index

2003
The efficacy and safety of brimonidine 0.2% compared with timolol 0.5% in glaucoma: a randomized clinical trial on Taiwanese patients.
    Journal of the Chinese Medical Association : JCMA, 2003, Volume: 66, Issue:5

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Brimonidine Tartrate; Female; Glaucoma; Heart; Humans; Male; Quinoxalines; Retrospective Studies; Timolol

2003
A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe.
    The British journal of ophthalmology, 2004, Volume: 88, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Europe; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Timolol; Treatment Outcome

2004
Diurnal intraocular pressure and blood pressure with two dosing regimens of brimonidine in normal tension glaucoma.
    Journal of the Chinese Medical Association : JCMA, 2004, Volume: 67, Issue:9

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Blood Pressure; Brimonidine Tartrate; Circadian Rhythm; Drug Administration Schedule; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Quinoxalines

2004
Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2005, Volume: 21, Issue:4

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Double-Blind Method; Drug Combinations; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quinoxalines; Timolol; Treatment Outcome

2005
A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Clinical therapeutics, 2006, Volume: 28, Issue:4

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Cloprostenol; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Quinoxalines; Sulfonamides; Thiazines; Timolol; Travoprost

2006
Visual field and intraocular pressure asymmetry in the low-pressure glaucoma treatment study.
    Ophthalmology, 2007, Volume: 114, Issue:3

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Aging; Brimonidine Tartrate; Circadian Rhythm; Double-Blind Method; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Quinoxalines; Timolol; Visual Fields

2007
Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension.
    Current medical research and opinion, 2008, Volume: 24, Issue:5

    Topics: Adult; Aged; Analysis of Variance; Brimonidine Tartrate; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Maximum Tolerated Dose; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Organization and Administration; Probability; Prostaglandins F, Synthetic; Quinoxalines; Risk Assessment; Severity of Illness Index; Single-Blind Method; Sulfonamides; Thiazines; Tonometry, Ocular; Treatment Outcome

2008
The efficacy of brimonidine in decreasing elevations in intraocular pressure after laser trabeculoplasty.
    Ophthalmology, 1993, Volume: 100, Issue:7

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Double-Blind Method; Drug Tolerance; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pharmaceutical Vehicles; Quinoxalines; Trabeculectomy

1993
Brimonidine in the prevention of intraocular pressure elevation following argon laser trabeculoplasty.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1993, Volume: 111, Issue:10

    Topics: Adrenergic alpha-Agonists; Adult; Antihypertensive Agents; Brimonidine Tartrate; Double-Blind Method; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Trabeculectomy

1993
Lack of cross-reactive allergic response to brimonidine in patients with known apraclonidine allergy.
    Eye (London, England), 1998, Volume: 12 ( Pt 4)

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Clonidine; Cross Reactions; Drug Hypersensitivity; Eye Diseases; Follow-Up Studies; Glaucoma; Humans; Middle Aged; Quinoxalines; Time Factors

1998
Pressure or progression?
    Archives of ophthalmology (Chicago, Ill. : 1960), 1999, Volume: 117, Issue:3

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Brimonidine Tartrate; Disease Progression; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Quinoxalines; Timolol; Visual Fields

1999
Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
    Ophthalmic surgery and lasers, 1999, Volume: 30, Issue:3

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Anterior Eye Segment; Brimonidine Tartrate; Chronic Disease; Clonidine; Female; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Male; Middle Aged; Observer Variation; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quinoxalines; Trabeculectomy; Treatment Outcome

1999
Efficacy of brimonidine 0.2% as adjunctive therapy for patients with glaucoma inadequately controlled with otherwise maximal medical therapy.
    Ophthalmology, 1999, Volume: 106, Issue:8

    Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Quinoxalines; Retrospective Studies; Safety; Treatment Outcome

1999
Daily cost of newer glaucoma agents.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1999, Volume: 15, Issue:5

    Topics: Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Gels; Glaucoma; Humans; Latanoprost; Prostaglandins F, Synthetic; Quinoxalines; Solutions; Sulfonamides; Thiophenes; Timolol

1999
The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension [corrected].
    American journal of ophthalmology, 1999, Volume: 128, Issue:6

    Topics: Administration, Topical; Adrenergic alpha-Agonists; Blood Flow Velocity; Brimonidine Tartrate; Disease Progression; Double-Blind Method; Female; Glaucoma; Humans; Intraocular Pressure; Laser-Doppler Flowmetry; Male; Middle Aged; Ocular Hypertension; Quinoxalines; Retinal Vessels; Visual Fields

1999
Ongoing clinical assessment of the safety profile and efficacy of brimonidine compared with timolol: year-three results. Brimonidine Study Group II.
    Clinical therapeutics, 2000, Volume: 22, Issue:1

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Blood Pressure; Brimonidine Tartrate; Double-Blind Method; Female; Glaucoma; Heart Rate; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quinoxalines; Timolol; Vision Tests

2000
Clinical success and quality of life with brimonidine 0.2% or timolol 0.5% used twice daily in glaucoma or ocular t hypertension: a randomized clinical trial. Brimonidine Outcomes Study Group I.
    Journal of glaucoma, 2000, Volume: 9, Issue:3

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Blood Pressure; Brimonidine Tartrate; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Female; Glaucoma; Heart Rate; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quality of Life; Quinoxalines; Safety; Surveys and Questionnaires; Timolol; Treatment Outcome

2000
[Treatment of glaucoma with brimonidine (Alphagan 0.2%)].
    Journal francais d'ophtalmologie, 2000, Volume: 23, Issue:8

    Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Child; Drug Therapy, Combination; Female; Glaucoma; Humans; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines

2000
Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension.
    Clinical therapeutics, 2001, Volume: 23, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Brimonidine Tartrate; Cross-Over Studies; Down-Regulation; Female; Glaucoma; Humans; Immunologic Factors; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quality of Life; Quinoxalines; Sulfonamides; Thiophenes

2001
Safety and efficacy of brimonidine in children with glaucoma.
    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2001, Volume: 5, Issue:5

    Topics: Adolescent; Adrenergic alpha-Agonists; Antihypertensive Agents; Brimonidine Tartrate; Central Nervous System Diseases; Child; Child, Preschool; Female; Glaucoma; Humans; Intraocular Pressure; Male; Ophthalmic Solutions; Quinoxalines; Safety; Tonometry, Ocular

2001
Twelve-month evaluation of brimonidine-purite versus brimonidine in patients with glaucoma or ocular hypertension.
    Journal of glaucoma, 2002, Volume: 11, Issue:2

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Conjunctivitis, Allergic; Double-Blind Method; Drug Evaluation; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Patient Satisfaction; Preservatives, Pharmaceutical; Quality of Life; Quinoxalines; Safety

2002

Other Studies

81 other study(ies) available for quinoxalines and Glaucoma

ArticleYear
Systemic toxicity from subcutaneous brimonidine injection successfully treated with naloxone.
    The American journal of emergency medicine, 2022, Volume: 59

    Topics: Adrenergic alpha-Agonists; Aged; Analgesics, Opioid; Bradycardia; Brimonidine Tartrate; Drug Overdose; Female; Glaucoma; Humans; Hypotension; Infant; Injections, Subcutaneous; Lethargy; Naloxone; Ophthalmic Solutions; Quinoxalines

2022
Cationic liposomes as promising vehicles for timolol/brimonidine combination ocular delivery in glaucoma: formulation development and in vitro/in vivo evaluation.
    Drug delivery and translational research, 2023, Volume: 13, Issue:4

    Topics: Animals; Antihypertensive Agents; Brimonidine Tartrate; Glaucoma; Intraocular Pressure; Liposomes; Polymers; Quinoxalines; Rabbits; Timolol

2023
Brimonidine.
    Profiles of drug substances, excipients, and related methodology, 2023, Volume: 48

    Topics: Adrenergic alpha-Agonists; Antihypertensive Agents; Brimonidine Tartrate; Glaucoma; Glaucoma, Open-Angle; Humans; Ophthalmic Solutions; Quinoxalines

2023
[Selective α2 agonists in the treatment of glaucoma: neuroprotective properties and impact on ocular blood flow].
    Vestnik oftalmologii, 2019, Volume: 135, Issue:3

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Brimonidine Tartrate; Glaucoma; Humans; Intraocular Pressure; Quinoxalines

2019
[Selective α2-agonists in the treatment of glaucoma: pharmacology, efficacy and safety].
    Vestnik oftalmologii, 2019, Volume: 135, Issue:2

    Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Glaucoma; Humans; Intraocular Pressure; Ophthalmic Solutions; Quinoxalines

2019
Novel topical ophthalmic formulations for management of glaucoma.
    Pharmaceutical research, 2013, Volume: 30, Issue:11

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Brimonidine Tartrate; Glaucoma; Lactic Acid; Mice; Nanoparticles; Ophthalmic Solutions; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quinoxalines

2013
Brinzolamide/brimonidine (Simbrinza) for glaucoma.
    The Medical letter on drugs and therapeutics, 2013, Jul-22, Volume: 55, Issue:1421

    Topics: Administration, Ophthalmic; Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Drug Combinations; Glaucoma; Humans; Quinoxalines; Sulfonamides; Thiazines

2013
Can ophthalmic drops cause central nervous system depression and cardiogenic shock in infants?
    Pediatric emergency care, 2013, Volume: 29, Issue:11

    Topics: Absorption; Administration, Ophthalmic; Apnea; Bradycardia; Brimonidine Tartrate; Consciousness Disorders; Dose-Response Relationship, Drug; Drug Combinations; Emergencies; Female; Glaucoma; Humans; Hypothermia; Infant; Muscle Hypotonia; Nasal Mucosa; Ophthalmic Solutions; Quinoxalines; Shock, Cardiogenic; Sulfonamides; Thiazines; Timolol

2013
[Current trend of glaucoma medication with various eye drops].
    Nippon Ganka Gakkai zasshi, 2013, Volume: 117, Issue:10

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Glaucoma; Humans; Latanoprost; Neuroprotective Agents; Ophthalmic Solutions; Ophthalmology; Prostaglandins; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes

2013
Mechanism - based translational pharmacokinetic - pharmacodynamic model to predict intraocular pressure lowering effect of drugs in patients with glaucoma or ocular hypertension.
    Pharmaceutical research, 2014, Volume: 31, Issue:8

    Topics: Animals; Antihypertensive Agents; Brimonidine Tartrate; Dogs; Female; Forecasting; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Models, Biological; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Rabbits; Translational Research, Biomedical; Treatment Outcome

2014
Transactivation of EGF receptors in chicken Müller cells by α2A-adrenergic receptors stimulated by brimonidine.
    Investigative ophthalmology & visual science, 2014, Apr-29, Volume: 55, Issue:6

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Blotting, Western; Brimonidine Tartrate; Cells, Cultured; Chick Embryo; Ependymoglial Cells; ErbB Receptors; Glaucoma; Immunohistochemistry; MAP Kinase Signaling System; Quinoxalines; Real-Time Polymerase Chain Reaction; Receptors, Adrenergic, alpha-2; Retina; RNA; Transcriptional Activation

2014
Brimonidine prevents neurodegeneration in a mouse model of normal tension glaucoma.
    Cell death & disease, 2014, Jul-17, Volume: 5

    Topics: Animals; Brimonidine Tartrate; Excitatory Amino Acid Transporter 3; Female; Glaucoma; Humans; Male; Mice; Mice, Knockout; Protective Agents; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Retinal Degeneration; Retinal Ganglion Cells

2014
Diadenosine tetraphosphate improves adrenergic anti-glaucomatous drug delivery and efficiency.
    Experimental eye research, 2015, Volume: 134

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Aqueous Humor; Blotting, Western; Brimonidine Tartrate; Cell Membrane Permeability; Cells, Cultured; Dinucleoside Phosphates; Drug Delivery Systems; Electric Impedance; Epithelium, Corneal; Glaucoma; Humans; Intraocular Pressure; Male; Occludin; Quinoxalines; Rabbits; Tight Junctions; Timolol; Zonula Occludens-1 Protein

2015
Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity.
    Investigative ophthalmology & visual science, 2008, Volume: 49, Issue:10

    Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Calcium; Calcium Signaling; Disease Models, Animal; Excitatory Amino Acid Agonists; Glaucoma; Male; N-Methylaspartate; Neuroprotective Agents; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Quinoxalines; Rabbits; Rats; Rats, Inbred BN; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, N-Methyl-D-Aspartate; Retina; Retinal Ganglion Cells; Rolipram

2008
A medical device/drug delivery system for treatment of glaucoma.
    Clinical & experimental optometry, 2009, Volume: 92, Issue:4

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Brimonidine Tartrate; Chromatography, High Pressure Liquid; Contact Lenses; Drug Delivery Systems; Female; Glaucoma; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Intraocular Pressure; Male; Middle Aged; Quinoxalines; Timolol

2009
Bilateral granulomatous uveitis as a side effect of topical brimonidine: two case reports.
    Bulletin de la Societe belge d'ophtalmologie, 2009, Issue:311

    Topics: Administration, Topical; Aged; Aged, 80 and over; Brimonidine Tartrate; Female; Glaucoma; Granuloma; Humans; Ophthalmic Solutions; Quinoxalines; Uveitis

2009
Reaction of Müller cells in an experimental rat model of increased intraocular pressure following timolol, latanoprost and brimonidine.
    Brain research bulletin, 2010, Apr-29, Volume: 82, Issue:1-2

    Topics: Animals; Antihypertensive Agents; Brimonidine Tartrate; Disease Models, Animal; Glaucoma; Glial Fibrillary Acidic Protein; Gliosis; Intraocular Pressure; Latanoprost; Male; Neuroglia; Prostaglandins F, Synthetic; Quinoxalines; Rats; Rats, Wistar; Retina; Timolol; Tonometry, Ocular

2010
Use of rituximab for periocular and intraocular mucosa-associated lymphoid tissue lymphoma.
    Ocular immunology and inflammation, 2010, Volume: 18, Issue:2

    Topics: Androstadienes; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Brimonidine Tartrate; Drug Therapy, Combination; Eye Neoplasms; Female; Glaucoma; Humans; Latanoprost; Loteprednol Etabonate; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Parotid Neoplasms; Prostaglandins F, Synthetic; Quinoxalines; Rituximab; Sulfonamides; Thiophenes; Timolol

2010
Alpha2-adrenergic receptors and their core involvement in the process of axonal growth in retinal explants.
    Investigative ophthalmology & visual science, 2010, Volume: 51, Issue:12

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Autoradiography; Axons; Brimonidine Tartrate; Clonidine; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Fluorescent Antibody Technique, Indirect; Glaucoma; Glial Fibrillary Acidic Protein; Optic Nerve Injuries; Organ Culture Techniques; Platelet Activating Factor; Protein Disulfide-Isomerases; Proteomics; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Laminin; Retina; Retinal Degeneration; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2010
Brimonidine hypersensitivity when switching between 0.2% and 0.15% formulations.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010, Volume: 26, Issue:4

    Topics: Administration, Topical; Adrenergic alpha-Agonists; Aged; Aged, 80 and over; Brimonidine Tartrate; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Hypersensitivity; Eye; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Quinoxalines; Treatment Outcome

2010
The clinical impact of 2 different strategies for initiating therapy in patients with ocular hypertension.
    Journal of glaucoma, 2011, Volume: 20, Issue:1

    Topics: Adult; Antihypertensive Agents; Blindness; Brimonidine Tartrate; Decision Trees; Disease Progression; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Markov Chains; Middle Aged; Models, Biological; Monte Carlo Method; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Risk Assessment; Sulfonamides; Thiophenes; Timolol

2011
Persistence of glaucoma medical therapy in the Glasgow Glaucoma Database.
    The British journal of ophthalmology, 2011, Volume: 95, Issue:7

    Topics: Algorithms; Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Clinical Protocols; Databases, Factual; Drug Utilization; Female; Glaucoma; Humans; Male; Ocular Hypertension; Quinoxalines; Scotland; Timolol

2011
Ocular perforation by an acupuncture needle.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2011, Volume: 46, Issue:1

    Topics: Acupuncture Therapy; Aged; Antihypertensive Agents; Brimonidine Tartrate; Combined Modality Therapy; Eye Injuries, Penetrating; Glaucoma; Humans; Laser Coagulation; Male; Needles; Needlestick Injuries; Quinoxalines; Retina; Retinal Perforations; Timolol; Visual Acuity; Vitrectomy; Vitreous Hemorrhage

2011
Nanovesicular formulation of brimonidine tartrate for the management of glaucoma: in vitro and in vivo evaluation.
    AAPS PharmSciTech, 2011, Volume: 12, Issue:2

    Topics: Animals; Brimonidine Tartrate; Chemistry, Pharmaceutical; Cornea; Disease Management; Drug Carriers; Glaucoma; Nanoparticles; Quinoxalines; Rabbits

2011
Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation.
    AAPS PharmSciTech, 2011, Volume: 12, Issue:4

    Topics: Acrylic Resins; Administration, Ophthalmic; Adrenergic alpha-2 Receptor Agonists; Animals; Brimonidine Tartrate; Chemistry, Pharmaceutical; Delayed-Action Preparations; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Stability; Glaucoma; Hydrogen-Ion Concentration; Intraocular Pressure; Kinetics; Nanoparticles; Nanotechnology; Quinoxalines; Rabbits; Solubility; Technology, Pharmaceutical

2011
[Pupillary block acute glaucoma due to acrylic intraocular lens posterior dislocation after Nd:YAG capsulotomy].
    Archivos de la Sociedad Espanola de Oftalmologia, 2011, Volume: 86, Issue:9

    Topics: Acute Disease; Aged; Brimonidine Tartrate; Combined Modality Therapy; Dipyrone; Drug Therapy, Combination; Emergencies; Female; Furosemide; Glaucoma; Hernia; Humans; Iris; Laser Therapy; Lasers, Solid-State; Lens Capsule, Crystalline; Lens Subluxation; Lenses, Intraocular; Mannitol; Metoclopramide; Postoperative Complications; Pseudophakia; Pupil Disorders; Quinoxalines; Timolol; Vitrectomy; Vitreous Body

2011
Polyamidoamine dendrimer hydrogel for enhanced delivery of antiglaucoma drugs.
    Nanomedicine : nanotechnology, biology, and medicine, 2012, Volume: 8, Issue:5

    Topics: Animals; Brimonidine Tartrate; Cattle; Cell Line; Dendrimers; Drug Combinations; Drug Delivery Systems; Epithelium, Corneal; Glaucoma; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Ophthalmic Solutions; Quinoxalines; Timolol

2012
Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.
    AAPS PharmSciTech, 2011, Volume: 12, Issue:4

    Topics: Absorbable Implants; Acrylic Resins; Administration, Ophthalmic; Adrenergic alpha-2 Receptor Agonists; Alginates; Animals; Brimonidine Tartrate; Calorimetry, Differential Scanning; Cellulose; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Drug Compounding; Glaucoma; Glucuronic Acid; Hexuronic Acids; Hydrophobic and Hydrophilic Interactions; Hypromellose Derivatives; Intraocular Pressure; Kinetics; Methylcellulose; Ophthalmic Solutions; Polymers; Polymethacrylic Acids; Polyvinyls; Povidone; Quinoxalines; Rabbits; Solubility; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical; X-Ray Diffraction

2011
Sustained ocular delivery of brimonidine tartrate using ion activated in situ gelling system.
    Current drug delivery, 2012, Volume: 9, Issue:2

    Topics: Animals; Biological Availability; Brimonidine Tartrate; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Delivery Systems; Drug Stability; Eye; Gels; Glaucoma; Hydrogen-Ion Concentration; Ions; Ophthalmic Solutions; Polysaccharides, Bacterial; Quinoxalines; Rabbits

2012
The activity of lowering intraocular pressure of cassiae seed extract in a DBA/2J mouse glaucoma model.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:1

    Topics: Acetazolamide; Animals; Antihypertensive Agents; Aqueous Humor; Brimonidine Tartrate; Cassia; Chromatography, High Pressure Liquid; Disease Models, Animal; Glaucoma; Glycosides; Intraocular Pressure; L-Lactate Dehydrogenase; Male; Mice; Mice, Inbred DBA; Plant Extracts; Polyphenols; Quinoxalines; Seeds

2013
[Pharmacological profile and clinical efficacy of brimonidine tartrate (AIPHAGAN(®) ophthalmic solution 0.1%)].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2012, Volume: 140, Issue:4

    Topics: Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Clinical Trials as Topic; Glaucoma; Humans; Intraocular Pressure; Ophthalmic Solutions; Quinoxalines

2012
[Use of glaucoma medications during pregnancy and breastfeeding].
    Archivos de la Sociedad Espanola de Oftalmologia, 2012, Volume: 87, Issue:12

    Topics: Abnormalities, Drug-Induced; Administration, Ophthalmic; Administration, Oral; Adrenergic beta-Antagonists; Animals; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Contraindications; Female; Fetus; Gels; Glaucoma; Humans; Hypotension; Intraocular Pressure; Lactation; Obstetric Labor, Premature; Ophthalmic Solutions; Pregnancy; Pregnancy Complications; Prostaglandins; Quinoxalines; Timolol

2012
Brimonidine-timolol fixed combination induced granulomatous inflammation of the eye.
    International ophthalmology, 2013, Volume: 33, Issue:5

    Topics: Antihypertensive Agents; Brimonidine Tartrate; Conjunctivitis; Drug Therapy, Combination; Female; Glaucoma; Humans; Male; Middle Aged; Quinoxalines; Timolol; Uveitis

2013
Discontinuation rates of topical glaucoma medications in a managed care population.
    The American journal of managed care, 2002, Volume: 8, Issue:10 Suppl

    Topics: Administration, Topical; Adult; Antihypertensive Agents; Brimonidine Tartrate; Chi-Square Distribution; Female; Glaucoma; Humans; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Patient Compliance; Proportional Hazards Models; Prostaglandins F, Synthetic; Quinoxalines; Retrospective Studies; Survival Analysis; Timolol

2002
Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model.
    Vision research, 2002, Volume: 42, Issue:20

    Topics: Aging; Analysis of Variance; Animals; Antihypertensive Agents; Brimonidine Tartrate; Cell Survival; Disease Models, Animal; Glaucoma; Memantine; Mice; Mice, Inbred DBA; Quinoxalines; Retinal Ganglion Cells; Timolol

2002
[Increased myopia and metaporphosia in a 59-year old patient. Serous retinal detachment of the posterior pol after latanoprost administration].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2003, Volume: 100, Issue:1

    Topics: Antihypertensive Agents; Blood-Retinal Barrier; Brimonidine Tartrate; Diagnosis, Differential; Drug Therapy, Combination; Fluorescein Angiography; Glaucoma; Humans; Latanoprost; Male; Middle Aged; Myopia; Prostaglandins F, Synthetic; Quinoxalines; Retinal Detachment; Visual Acuity

2003
Cystoid macular oedema associated with brimonidine therapy.
    Clinical & experimental ophthalmology, 2003, Volume: 31, Issue:2

    Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Female; Fluorescein Angiography; Glaucoma; Humans; Macular Edema; Quinoxalines

2003
Hypotension and bradycardia in infants after the use of topical brimonidine and beta-blockers.
    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2003, Volume: 7, Issue:1

    Topics: Administration, Topical; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Bradycardia; Brimonidine Tartrate; Female; Glaucoma; Humans; Hypotension; Infant; Infant, Newborn; Intraocular Pressure; Quinoxalines

2003
Effects of commercial antiglaucoma drugs to glutamate-induced [Ca2+)]i increase in cultured neuroblastoma cells.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2003, Volume: 19, Issue:3

    Topics: Animals; Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Calcium; Carteolol; Cell Death; Dose-Response Relationship, Drug; Epinephrine; Glaucoma; Glutamic Acid; Latanoprost; Mice; Neuroblastoma; Neurons; Neuroprotective Agents; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Thiophenes; Timolol; Tumor Cells, Cultured

2003
Patient persistency with pharmacotherapy in the management of glaucoma.
    European journal of ophthalmology, 2003, Volume: 13 Suppl 4

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Brimonidine Tartrate; Cohort Studies; Drug Utilization; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Middle Aged; Ocular Hypertension; Patient Compliance; Prostaglandins F, Synthetic; Quinoxalines; Retrospective Studies; Sulfonamides; Thiophenes

2003
Prescription of topical antiglaucoma agents for patients with contraindications to beta-blockers.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2003, Volume: 38, Issue:6

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Contraindications; Databases, Factual; Drug Prescriptions; Female; Glaucoma; Humans; Latanoprost; Male; Middle Aged; National Health Programs; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quebec; Quinoxalines; Retrospective Studies; Sulfonamides; Thiophenes; Timolol

2003
Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan) in children.
    Eye (London, England), 2004, Volume: 18, Issue:1

    Topics: Adolescent; Adrenergic alpha-Agonists; Antihypertensive Agents; Brimonidine Tartrate; Child; Child, Preschool; Eye Diseases; Female; Glaucoma; Humans; Infant; Infant, Newborn; Male; Ophthalmic Solutions; Quinoxalines; Sleep Stages; Syncope

2004
Demographic and clinical factors associated with development of brimonidine tartrate 0.2%-induced ocular allergy.
    Journal of glaucoma, 2004, Volume: 13, Issue:2

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Conjunctivitis, Allergic; Demography; Dermatitis, Allergic Contact; Drug Hypersensitivity; Eyelid Diseases; Female; Glaucoma; Humans; Male; Middle Aged; Ophthalmic Solutions; Quinoxalines; Retrospective Studies; Risk Factors

2004
Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2% brimonidine tartrate.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:7

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Conjunctivitis, Allergic; Female; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Male; Ophthalmic Solutions; Prednisolone; Quinoxalines; Uveitis, Anterior

2004
Alphagan allergy may increase the propensity for multiple eye-drop allergy.
    Eye (London, England), 2005, Volume: 19, Issue:2

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Cross Reactions; Drug Administration Schedule; Drug Hypersensitivity; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Longitudinal Studies; Male; Middle Aged; Ophthalmic Solutions; Quinoxalines; Retrospective Studies; Sulfonamides; Thiophenes; Timolol

2005
Prospective survey of adverse reactions to topical antiglaucoma medications in a hospital population.
    Eye (London, England), 2005, Volume: 19, Issue:4

    Topics: Adrenergic alpha-Agonists; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Female; Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Outpatient Clinics, Hospital; Patient Acceptance of Health Care; Prospective Studies; Quinoxalines; Time Factors

2005
[Neuroprotection and vasoprotection in glaucoma].
    Oftalmologia (Bucharest, Romania : 1990), 2004, Volume: 48, Issue:2

    Topics: Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Carteolol; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Neuroprotective Agents; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Treatment Outcome

2004
Cost considerations of the new fixed combinations for glaucoma medical therapy.
    Journal of clinical pharmacy and therapeutics, 2005, Volume: 30, Issue:3

    Topics: Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Canada; Drug Combinations; Glaucoma; Humans; Latanoprost; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Timolol

2005
Side-effect profile of brimonidine tartrate in children.
    Ophthalmology, 2005, Volume: 112, Issue:12

    Topics: Adolescent; Adrenergic alpha-Agonists; Brimonidine Tartrate; Central Nervous System Diseases; Child; Child, Preschool; Female; Glaucoma; Humans; Infant; Intraocular Pressure; Male; Prospective Studies; Quinoxalines; Risk Factors; Sleep; Sleep Stages; Surveys and Questionnaires

2005
Argon laser trabeculoplasty and reduction of ocular hypotensive medication used by glaucoma patients.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2006, Volume: 41, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Chronic Disease; Circadian Rhythm; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Male; Middle Aged; Quinoxalines; Trabeculectomy; Treatment Outcome

2006
[Ocular hypertension in children treated with brimonidine 0.2%. A clinical study].
    Archivos de la Sociedad Espanola de Oftalmologia, 2006, Volume: 81, Issue:3

    Topics: Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Child; Female; Glaucoma; Humans; Intraocular Pressure; Male; Ocular Hypertension; Quinoxalines; Retrospective Studies; Treatment Outcome

2006
Is brimonidine ophthalmic a safe therapy for infants?
    Journal of clinical pharmacy and therapeutics, 2006, Volume: 31, Issue:3

    Topics: Adrenergic alpha-Agonists; Bradycardia; Brimonidine Tartrate; Glaucoma; Humans; Hypotension; Infant; Male; Ophthalmic Solutions; Quinoxalines

2006
[Intraocular pressure after ND: YAG laser capsulotomy in pseudophakic patients with glaucoma].
    Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2006, Volume: 60, Issue:2

    Topics: Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Cataract Extraction; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Lens Capsule, Crystalline; Preoperative Care; Pseudophakia; Quinoxalines; Sulfonamides; Thiophenes

2006
Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs.
    The British journal of ophthalmology, 2007, Volume: 91, Issue:1

    Topics: Administration, Topical; Aged; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Carteolol; Case-Control Studies; Chemokines; Cloprostenol; Cytokines; Dose-Response Relationship, Immunologic; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Lipids; Male; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Tears; Thiophenes; Timolol

2007
Brimonidine/Timolol: a viewpoint by Richard Fiscella.
    Drugs & aging, 2006, Volume: 23, Issue:9

    Topics: Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Quinoxalines; Randomized Controlled Trials as Topic; Timolol; Treatment Outcome

2006
Brimonidine/Timolol: a viewpoint by Robert M. Feldman.
    Drugs & aging, 2006, Volume: 23, Issue:9

    Topics: Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Glaucoma; Humans; Prostaglandins F, Synthetic; Quinoxalines; Timolol

2006
Brimonidine/Timolol: a viewpoint by Francisco J. Goñi.
    Drugs & aging, 2006, Volume: 23, Issue:9

    Topics: Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Quinoxalines; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes; Timolol; Treatment Outcome

2006
[Depression of respiration via toxic effects on the central nervous system following use of topical brimonidine in an infant with congenital glaucoma].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2007, Volume: 104, Issue:6

    Topics: Antihypertensive Agents; Apnea; Brimonidine Tartrate; Cataract; Female; Glaucoma; Humans; Infant, Newborn; Infant, Premature, Diseases; Neurotoxicity Syndromes; Ophthalmic Solutions; Postoperative Complications; Quinoxalines; Respiratory Insufficiency; Trabeculectomy

2007
New drug information. Combigan.
    JAAPA : official journal of the American Academy of Physician Assistants, 2008, Volume: 21, Issue:2

    Topics: Antihypertensive Agents; Brimonidine Tartrate; Glaucoma; Humans; Intraocular Pressure; Quinoxalines; Timolol

2008
New agents for the treatment of glaucoma.
    The Western journal of medicine, 1997, Volume: 166, Issue:2

    Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Prostaglandins F, Synthetic; Quinoxalines

1997
Brimonidine--an alpha 2-agonist for glaucoma.
    The Medical letter on drugs and therapeutics, 1997, Jun-06, Volume: 39, Issue:1002

    Topics: Administration, Topical; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Brimonidine Tartrate; Clinical Trials as Topic; Contraindications; Glaucoma; Humans; Intraocular Pressure; Quinoxalines; Xerostomia

1997
Update in glaucoma: the new pharmacotherapies. Brimonidine versus apraclonidine.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1998, Volume: 33, Issue:5

    Topics: Adrenergic alpha-Agonists; Antihypertensive Agents; Brimonidine Tartrate; Clonidine; Glaucoma; Humans; Quinoxalines

1998
[Modern anti-glaucoma drugs and their secondary effects].
    Revue medicale de la Suisse romande, 1998, Volume: 118, Issue:11

    Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Dinoprost; Glaucoma; Humans; Quinoxalines; Sulfonamides; Thiophenes

1998
The effect of latanoprost and brimonidine on rabbit subconjunctival fibroblasts.
    Journal of glaucoma, 1999, Volume: 8, Issue:1

    Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Cell Count; Cell Division; Conjunctiva; Disease Models, Animal; Fibroblasts; Glaucoma; Intraocular Pressure; Latanoprost; Microfilament Proteins; Ophthalmic Solutions; Proliferating Cell Nuclear Antigen; Prostaglandins F, Synthetic; Quinoxalines; Rabbits

1999
[Four new drugs for glaucoma: apraclonidine, brimonidine, dorzolamide and latanoprost].
    Nederlands tijdschrift voor geneeskunde, 1999, Jan-30, Volume: 143, Issue:5

    Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Clonidine; Drug Approval; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Netherlands; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes

1999
Systemic adverse effects of topical treatment with brimonidine in an infant with secondary glaucoma.
    European journal of pediatrics, 1999, Volume: 158, Issue:8

    Topics: Adrenergic alpha-Agonists; Blood-Brain Barrier; Brimonidine Tartrate; Central Nervous System; Glaucoma; Humans; Infant; Quinoxalines

1999
Apparent central nervous system depression in infants after the use of topical brimonidine.
    American journal of ophthalmology, 1999, Volume: 128, Issue:2

    Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Central Nervous System; Follow-Up Studies; Glaucoma; Humans; Infant; Infant, Newborn; Intraocular Pressure; Male; Nervous System Diseases; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines

1999
Demonstration of the reversibility of optic disc topography by scanning laser ophthalmoscopy.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1999, Volume: 117, Issue:12

    Topics: Adrenergic alpha-Agonists; Aniridia; Brimonidine Tartrate; Child; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Lasers; Latanoprost; Male; Ophthalmoscopy; Optic Disk; Optic Nerve Diseases; Prostaglandins F, Synthetic; Quinoxalines; Trabeculectomy; Visual Acuity

1999
Incidence of brimonidine allergy in patients previously allergic to apraclonidine.
    Journal of glaucoma, 2000, Volume: 9, Issue:3

    Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Clonidine; Conjunctivitis; Cross Reactions; Dermatitis, Allergic Contact; Drug Hypersensitivity; Female; Glaucoma; Humans; Hyperemia; Incidence; Male; Middle Aged; Quinoxalines; Retrospective Studies; Risk Factors

2000
Anterior uveitis as a side effect of topical brimonidine.
    American journal of ophthalmology, 2000, Volume: 130, Issue:3

    Topics: Acute Disease; Administration, Topical; Adrenergic alpha-Agonists; Aged; Aged, 80 and over; Anterior Eye Segment; Brimonidine Tartrate; Female; Glaucoma; Humans; Intraocular Pressure; Male; Ophthalmic Solutions; Quinoxalines; Recurrence; Uveitis, Anterior; Visual Acuity

2000
Comparison of the ocular hypotensive effect of brimonidine, dorzolamide, latanoprost, or artificial tears added to timolol in glaucomatous monkey eyes.
    Journal of glaucoma, 2000, Volume: 9, Issue:6

    Topics: Animals; Antihypertensive Agents; Brimonidine Tartrate; Drug Synergism; Drug Therapy, Combination; Female; Glaucoma; Intraocular Pressure; Latanoprost; Macaca fascicularis; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Random Allocation; Sulfonamides; Thiophenes; Timolol

2000
[Neuroprotection. Bases and possibilities of a future clinical use].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2001, Volume: 98, Issue:3

    Topics: Adrenergic alpha-Agonists; Animals; Apoptosis; Brimonidine Tartrate; Clinical Trials as Topic; Disease Models, Animal; Dopamine Agents; Eye Diseases; Forecasting; Glaucoma; Humans; Memantine; Neuroprotective Agents; Optic Neuritis; Quinoxalines; Retinal Diseases; Visual Fields

2001
Quantitation of mitomycin C in human ocular tissues by high-performance liquid chromatography-photo-diode array detection.
    Journal of chromatography. B, Biomedical sciences and applications, 2001, May-05, Volume: 755, Issue:1-2

    Topics: Antihypertensive Agents; Brimonidine Tartrate; Chromatography, High Pressure Liquid; Glaucoma; Humans; Mitomycin; Molecular Structure; Premedication; Quinoxalines; Sclera; Timolol; Trabeculectomy

2001
Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure.
    Brain research, 2001, Sep-21, Volume: 913, Issue:2

    Topics: Adrenergic alpha-Antagonists; Age Factors; Animals; Brimonidine Tartrate; Cell Count; Cell Survival; Disease Models, Animal; Female; Glaucoma; Intraocular Pressure; Nerve Degeneration; Neuroprotective Agents; Quinoxalines; Rats; Rats, Wistar; Retinal Ganglion Cells; Time Factors

2001
[Experience with topical brimonidine in the treatment of glaucomas].
    Journal francais d'ophtalmologie, 2001, Volume: 24, Issue:7

    Topics: Antihypertensive Agents; Brimonidine Tartrate; Glaucoma; Humans; Quinoxalines

2001
[Prospects for neuroprotective glaucoma therapy].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2001, Volume: 98, Issue:10

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Apoptosis; Betaxolol; Brain-Derived Neurotrophic Factor; Brimonidine Tartrate; Calcium Channel Blockers; Disease Models, Animal; Dopamine Agents; Glaucoma; Glaucoma, Open-Angle; Haplorhini; Humans; Memantine; Neuroprotective Agents; Nimodipine; Nitric Oxide Synthase; Quinoxalines; Receptors, N-Methyl-D-Aspartate

2001
The impact of new drugs on management of glaucoma in Scotland: observational study.
    BMJ (Clinical research ed.), 2001, Dec-15, Volume: 323, Issue:7326

    Topics: Adrenergic alpha-Agonists; Antihypertensive Agents; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Drug Utilization; Glaucoma; Humans; Practice Patterns, Physicians'; Prostaglandins, Synthetic; Quinoxalines; Scotland; Trabeculectomy

2001
Allergic reactions to brimonidine in patients treated for glaucoma.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2002, Volume: 37, Issue:1

    Topics: Adrenergic alpha-Agonists; Aged; Antihypertensive Agents; Brimonidine Tartrate; Conjunctivitis, Allergic; Dermatitis, Allergic Contact; Drug Hypersensitivity; Female; Glaucoma; Humans; Levobunolol; Male; Quinoxalines; Retrospective Studies; Seasons

2002
The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care.
    The British journal of ophthalmology, 2002, Volume: 86, Issue:5

    Topics: Administration, Topical; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Drug Costs; Drug Prescriptions; Glaucoma; Humans; Latanoprost; Middle Aged; Miotics; Prostaglandins F, Synthetic; Prostaglandins, Synthetic; Quinoxalines; Retrospective Studies; Scotland; Sulfonamides; Sympathomimetics; Thiophenes; Trabeculectomy

2002
Brimonidine 0.2% to prevent post laser IOP elevation.
    Ophthalmology, 2002, Volume: 109, Issue:5

    Topics: Antihypertensive Agents; Brimonidine Tartrate; Glaucoma; Humans; Intraocular Pressure; Iris; Laser Therapy; Ocular Hypertension; Postoperative Complications; Quinoxalines; Trabeculectomy

2002
Additive intraocular pressure lowering effect of various medications with latanoprost.
    American journal of ophthalmology, 2002, Volume: 133, Issue:6

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Drug Synergism; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Prostaglandins F, Synthetic; Quinoxalines; Retrospective Studies; Sulfonamides; Thiophenes

2002